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Abstract
Background: Gangliosides, sialic acid-containing glycosphingolipids exist in mammalian cell membranes particularly 
neuronal membranes. The trisialoganglioside (GT1b) is one of the major brain gangliosides and acts as an endogenous 
regulator in the brain. We previously showed GT1b induces mesencephalic dopaminergic (DA) neuronal death, both in 
vivo and in vitro. We further investigate the underlying mechanisms of GT1b neurotoxicity.
Results: Consistent with earlier findings, GT1b attenuated the DA neuron number and dopamine uptake level in 
mesencephalic cultures. Morphological evidence revealed GT1b-induced chromatin condensation and nuclear 
fragmentation as well as an increased number of TUNEL-positive cells, compared to control cultures. Interestingly, 
while GT1b enhanced caspase-3 activity, DEVD, a caspase-3 inhibitor, failed to rescue DA neuronal death. Immunoblot 
analysis revealed that GT1b inactivates Akt through dephosphorylation at both Ser473 and Thr308, subsequent 
dephosphorylation of GSK-3β, a substrate of Akt, and hyperphosphorylation of tau, downstream of GSK-3β. Moreover, a 
GSK-3β specific inhibitor, L803-mt, attenuated tau phosphorylation and rescued DA neurons from cell death in 
mesencephalic cultures.
Conclusion: Our data provide novel evidence that a Akt/GSK-3β/tau-dependent, but not caspase-3 signaling pathway 
plays a pivotal role in GT1b-mediated neurotoxic actions on mesencephalic DA neurons.
Background
The progressive degeneration of dopaminergic (DA) neu-
rons in the substantia nigra (SN) is a well-known charac-
teristic of Parkinson's disease (PD). In vivo and in vitro
models of PD induced by 1-methyl-4-phenyl-1,2,3,6-tet-
rahydropyridine (MPTP), 1-methyl-4-phenylpyridinium
(MPP+) or 6-hydroxydopamine (6-OHDA) reveal that
apoptosis is the principal mechanism underlying neu-
ronal death [1-4].
The Akt/glycogen synthase kinase (GSK)-3β/caspase-3
signaling pathways are among the essential components
regulating apoptosis [5,6]. Recently, transduction of DA
neurons with myristoylated Akt (Myr-Akt), a constitu-
tively active form of Akt prevents 6-OHDA-induced cel-
l u l a r  a n d  f u n c t i o n a l  d a m a g e  o f  D A  n e u r o n s  [ 7 ] ,
Moreover, increased phospho-Akt levels in LINGO-1
knockout mice provide potent protection of DA neurons
in 6-OHDA- or N-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine neurotoxicity [8]. Several lines of evidence indi-
c a t e  t h a t  G S K - 3 β  m e d i a t e s  D A  n e u r o n a l  d e a t h  i n  P D
animal models produced by MPTP [9] or 6-OHDA [10].
In addition, tau, a well-known substrate for GSK-3β
[11,12], mediates DA neuronal death in MPTP-treated
mice [9]. Significantly, a number of studies show that cas-
pase-3 contributes to cell death of DA neurons in human
PD postmortem brain tissue, animal models of PD, pri-
mary cultures of rat mesencephalon, and SN-derived DA
cell lines [1,3,4,13].
Gangliosides, sialic acid-containing glycosphingolipids
that exist in mammalian cell membranes, are particularly
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enriched in neuronal membranes [14]. A variety of neu-
rodegenerative disorders are associated with increased
ganglioside levels in cerebrospinal fluid (CSF) [15-17].
Furthermore, gangliosides localized to neurofibrillary
tangles (senile plaques) in brain tissue of Alzheimer's dis-
ease (AD) patients and Betz cells of precentral gyrus in
amyotrophic lateral sclerosis patients [18,19]. These find-
ings support the possibility that under pathological con-
ditions, gangliosides serve as cytotoxic factors in the
central nervous system (CNS).
Trisialoganglioside, GT1b, one of the major brain gan-
glioside [14,20], possibly acts as an endogenous regulator
in the brain. GT1b induces apoptosis in non-neuronal
cells, such as thymocytes [21] and keratinocytes [22].
Moreover, neurotoxic activity of GT1b against DA neu-
rons has been reported in the SN in vivo [23] and mesen-
cephalic cultures [24]. However, the mechanisms
underlying GT1b-induced DA neuronal death are not
clarified.
In this study, we demonstrate for the first time that
GT1b neurotoxicity is accompanied by inactivation of
Akt, activation of GSK-3β and increase in tau phosphory-
lation in mesencephalic DA neurons, both in vivo and in
vitro. Our data further confirm that caspase-3 is not a
major effector of DA neuronal death in GT1b neurotoxic-
ity.
Results
Characterization of GT1b-induced neurotoxicity in neuron-
enriched mesencephalic cultures
Consistent with our previous findings [24], 10-60 mg/ml
GT1b significantly attenuated the number of TH-ip neu-
rons by 26-68% and the levels of [3H] DA uptake by 31-
60% in a dose-dependent manner (Figure 1A,B,C). To
selectivity, additional immunostaining was performed
with a NeuN antibody for general neurons and GABA
antibody for GABAergic neurons (Figure 1D). Treatment
with 20 mg/ml GT1b significantly reduced the number of
NeuN-ip neurons by 50%, GABA-ip neurons by 54% and
TH-ip neurons by 50%, compared with non-treated con-
trol cultures.
Several morphological and biochemical assays were
conducted to further ascertain the mode of cell death and
association with caspases. As shown in Figure 2A-D,
DNA fragmentation in mesencephalic cultures was con-
firmed with the TUNEL reaction. The TUNEL-positive
(+) cell population was increased in GT1b-treated cul-
tures (Figure 2C), compared with non-treated control
cultures (Figure 2A). Hoechst 33258 nuclear staining
clearly disclosed condensation and fragmentation of
nuclei in GT1b-treated (Figure 2D) but not control cul-
tures (Figure 2B). The percentage of TUNEL (+) cells
ranged from 15% to 41%, as determined from the ratio of
TUNEL (+) cells to Hoechst 33258 (+) total neuronal cells
at the indicated time-points (Figure 2E).
To discriminate between DA and non-DA neurons,
mesencephalic cultures were immunostained with a TH
antibody specific for DA neurons and electron micro-
graphs obtained. In control cultures, both DA (Figure 2F)
and non-DA neurons (Figure 2H) contained intact nuclei
with well-preserved cell membranes. In contrast, frag-
mented nuclei were clearly visible in both DA (Figure 2G)
and non-DA neurons (Figure 2I) with a fairly intact cell
membrane in GT1b-treated cultures.
GT1b neurotoxicity is independent of caspase-3
Accumulating evidence supports the theory that nuclear
DNA fragmentation results from activation of caspase-3,
which plays a pivotal role in DA neuronal death [3].
Accordingly, to determine whether caspase-3 is involved
in GT1b-induced neurotoxicity, cultures were treated
with 20 mg/ml GT1b, and caspase-3 activity assessed in
cell extracts by monitoring cleavage of its fluorogenic
substrate, DEVD-AFC, at indicated time-points. In
GT1b-treated cultures, caspase-3 activity was approxi-
Figure 1 Neurotoxicity induced by GT1b in neuron-enriched 
mesencephalic cultures. (A,B) Cultures were treated with 20 μg/ml 
GT1b for 24 h and then immunostained with TH antibody. Note a sig-
nificant loss of TH-ip neurons in mesencephalic cultures following 
treatment with GT1b (B), compared with untreated control cultures 
(A). Most of remaining neurons had the short process (white arrows) 
and rounded and shrunken cell bodies (black arrows). Scale bar, 50 μm. 
(C) TH-ip neurons were counted or the levels of [3H]dopamine uptake 
were measured in cultures treated with 2-60 μg/ml GT1b for 24 h. The 
results are expressed as a percentage of the control cultures. (D) Re-
duction in the number of NeuN-ip, GABA-ip and TH-ip neurons in cul-
tures treated with 20 μg/ml GT1b for 24 h. The values represent the 
mean ± SEM of triplicate cultures in four separate samples; *P < 0.05, 
**P < 0.001, significantly different from each control cultures (ANOVA 
and Student-Newman-Keuls analyses).Chung et al. BMC Neuroscience 2010, 11:74
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mately 2 and 4-fold higher than that in control cultures at
16 h and 24 h, respectively (Figure 3A).
Next we examined whether caspase inhibitors block
G T 1 b  n e u r o t o x i c i t y .  C u l t u r e s  w e r e  t r e a t e d  w i t h  a  c a s -
pase-3-specific inhibitor, DEVD, or a non-specific cas-
pase inhibitor, z-VAD, together with or without GT1b.
Surprisingly, neither DEVD nor z-VAD rescued GT1b-
induced DA neurotoxicity, as evident from TH-ip neuron
counts and level of [3H]dopamine uptake (Figure 3B),
although the caspase-3-specific inhibitor (DEVD) signifi-
cantly attenuated caspase-3 activity (Figure 3A). z-VAD
or DEVE only as controls had no effects (Additional file
1E). However, DEVD inhibits not only caspase-3 but also
caspase-1 and -2. Thus additional experiments were per-
formed using more specific caspase-3 inhibitor, z-
DQMD-FMK [25]. Similar to DEVE, z-DQMD-FMK was
unable to prevent GT1b neurotoxicity as evidence by TH
immunocytochemistry (Additional file 1).
GT1b promotes inactivation of Akt and subsequent 
activation of GSK-3β
The Akt signaling pathway is essential for the survival of
various cell types [26,27], including DA neurons [7]. Spe-
cific PD-related pathological challenges by dephosphory-
lation/inactivation of Akt and dephosphorylation/
activation of its downstream substrate, GSK-3β may be
associated with MPP+- or 6-OHDA-induced neurotoxic-
ity [10,28]. To examine the involvement of Akt in GT1b
neurotoxicity, cultures were treated with 20 mg/ml GT1b,
and Western blotting analysis performed using phospho-
Akt (Ser473) or phospho-Akt (Thr308) antibody at the
Figure 3 Neurotoxicity of GT1b was not mediated Caspase-3 in 
neuron-enriched mesencephalic cultures. Activity of caspase-3 was 
measured by DEVD-AFC cleavage (A), and expressed as the amount of 
Δ AFC per 1 h in cultures treated with 20 μg/ml GT1b in the absence or 
the presence of caspase-3 inhibitor (DEVD, 10 μM) at the indicated 
time points. (B) Number of TH-ip neurons and the levels of [3H]dop-
amine uptake were assessed in cultures treated with 20 μg/ml GT1b for 
24 h in the absence or the presence of caspase inhibitors, z-VAD (100 
μM) or DEVD (10 μM). The values represent the mean ± SEM of tripli-
cate cultures in four separate samples; *P < 0.05, **P < 0.001, signifi-
cantly different from control cultures (ANOVA and Student-Newman-
Keuls analyses).
Figure 2 Neurotoxicity induced by GT1b in neuron-enriched 
mesencephalic cultures. (A-D) TUNEL reaction showing DNA frag-
mentation in the absence (A) or presence (C) of 20 μg/ml GT1b for 24 
h in neuron-enriched mesencephalic cultures. B and D, Hoechst 33258 
counterstaining of A and C, respectively. Inset, highly magnified cell in-
dicated by arrow. Scale bar, 50 μm. (E) TUNEL (+) cells were counted 
and expressed as a percentage of Hoechst 33258(+) total cells in con-
trol cultures (opened circles) or in cultures treated with 20 μg/ml GT1b 
(filled circles) at indicated time points. The values represent the mean 
± SEM of triplicate cultures in three separate samples; *P < 0.001, signif-
icantly different from control cultures (ANOVA and Student-Newman-
Keuls analyses). (F-I) Electron microscopic observations showed mor-
phology of neuronal cell death in the absence (F and H) or presence (G 
and I) of 20 μg/ml GT1b for 24 h. To distinguish DA neurons from non-
DA neurons, cultures were immunostained with TH antibody and then 
electron micrographs taken. Nucleus was well-preserved with fairly in-
tact cell membrane in the control cultures of DA (F) or non-DA (H) neu-
rons. Note that following GT1b, fragmented nuclei were clearly visible 
in DA (G) or non-DA (I) neurons. CM, cell membrane; N, nucleus; NM, 
nuclear membrane. Scale bar, 5 μm.Chung et al. BMC Neuroscience 2010, 11:74
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indicated time-points. Decrease in Akt phosphorylation
at both Ser473 and Thr308 was detected as early as 2 h,
and sustained up to 8 h in GT1b-treated cultures (Figure
4A,B). Additionally, Akt kinase activity was measured by
assessing phosphorylation of its substrate, GSK-3α/β
fusion protein by immunoprecipitated Akt. Akt kinase
activity, quantified and expressed as a percentage of
phosphorylated GSK-3α/β to total Akt, was inhibited by
56% as early as 2 h after the application of 20 μg/ml
GT1b, compared to control cultures (0 h) (Figure 4C,D).
Figure 4 Reduction in phosphorylation/activation of Akt by GT1b. (A) Phosphorylation of Akt was detected by immunoblotting with phospho-
Akt (Ser473) and phospho-Akt (Thr308) antibody in cultures treated with 20 μg/ml GT1b at indicated time points. (B) The histogram shows quantifi-
cation of phospho-Akt levels. (C-F) The activity of Akt was measured using immunoprecipitated Akt, and then it was mixed with the GSK-3α/β fusion 
protein (1 μg/assay). Phosphorylated GSK-3α/β was detected by immunoblotting with phospho-GSK-3α/β antibody. (D,F) The histograms show quan-
tification of phospho-GSK-3α/β levels of C and E, respectively. The values represent the mean ± SEM of four to five separate experiments; *P < 0.01, 
**P < 0.001, significant from non-treated control cultures (0 h) (ANOVA and Student-Newman-Keuls analyses).Chung et al. BMC Neuroscience 2010, 11:74
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GT1b (10-60 μg/ml) significantly attenuated Akt kinase
activity (by 22-68%) at 6 h post-treatment, compared with
non-treated control cultures (Figure 4E,F).
G S K - 3 β  i s  a  m a j o r  s u b s t r a t e  o f  A k t .  P h y s i o l o g i c a l l y ,
activated Akt inhibits GSK-3β activity by enhancing
phosphorylation at Ser9, consequently promoting cell
survival [29]. Accordingly, we hypothesize that the
decrease in phospho-Akt, in turn, reduces GSK-3β phos-
phorylation, leading to its activation and eventual cell
death. To examine this theory, Western blotting analysis
was performed using a phospho-GSK-3β (Ser9) antibody.
As shown in Figure 5A, GSK-3β phosphorylation was
decreased by 12-41% at specific time-points, compared
with control cultures (0 h) (Figure 5B).
To assess whether suppression of GSK-3β activity
blocks GT1b neurotoxicity, cultures were treated with the
GSK-3β-specific inhibitor, L803-mt (20 μM) [10],
together with GT1b for 24 h. L803-mt rescued TH-ip
neuron death by 53% in relation to GT1b-treated cultures
(Figure 5C). However, L803-mt alone had no effect (data
not shown).
GT1b induces tau hyperphosphorylation through GSK-3β 
activation
Tau is phosphorylated by GSK-3β activated as a result of
Akt inactivation [6]. Earlier studies show that hyperphos-
phorylation of tau inhibits its binding to microtubules,
resulting in neuronal cell death [30]. Accordingly, we
examined whether GT1b enhances tau phosphorylation.
Cultures were treated with vehicle as controls (Figure 6A)
or 20 ug/ml GT1b for 8 h (Figure 6B) and double-immnu-
ostained with the AT8 antibody for phospho-tau (Ser202,
Green) and TH antibody for DA neurons (Red). The
results revealed that following GT1b treatment, AT8-ip-
phosphorylated tau was localized within both TH-ip
(arrow) and non-TH-ip neurons (arrowhead) with
strongly stained soma and processes (Figure 6B), com-
pared to control (Figure 6A). Consistent with our previ-
ous results [23], intranigral injection of GT1b induced
degeneration of TH-ip neurons in the ipsilateral SN (Fig-
ure 6C), compared with the contralateral side (data not
shown) at 72 h post-treatment. Additional double immu-
nostaining using SN tissues revealed that phosphorylated
tau (Figure 6G, green) and TH-ip neurons (Fg.6G, red)
co-localize in GT1b-injected SN (Figure 6I, yellow). Few
AT8-ip neurons were visible in PBS injected SN as con-
trols (Figure 6D-F).
Additional Western blot analyses disclosed that 20 μg/
ml GT1b significantly upregulated tau phosphorylation
in a time-dependent manner (Figure 6J,K). To assess
whether suppression of GSK-3β activity affects the tau
hyperphosphorylation level, cultures were treated with a
GSK-3β specific inhibitor, L803-mt, together with GT1b
for 16 h. L803-mt reversed tau hyperphosphorylation by
47%, compared to GT1b-treated cultures (Figure 6L,M).
Figure 5 GT1b increases the activity GSK-3β by dephosphoryla-
tion in neuron-enriched mesencephalic cultures. (A) Western blot 
analysis showing dephosphorylation of GSK-3β in GT1b-treated cul-
tures. Cell lysates were analyzed by Western blot analysis with phos-
pho-GSK-3β (Ser9) antibody at indicated time points. After membrane 
stripping, blots were reprobed with total GSK-3β. (B) The histogram 
shows quantification of phospho-GSK-3β levels. The values represent 
the mean ± SEM of four separate experiments; *P < 0.001, significant 
from non-treated control cultures (0 h) (ANOVA and Student-New-
man-Keuls analyses). (C) TH-ip neurons were counted in cultures treat-
ed with 20 μg/ml GT1b for 24 h in the absence or presence of 20 μM 
L803-mt, GSK-3β specific inhibitor. The values represent the mean ± 
SEM of triplicate cultures in three to five separate samples. *P < 0.001, 
significant from non-treated control cultures; #P < 0.01, significant from 
GT1b-treated cultures (ANOVA and Student-Newman-Keuls analyses).Chung et al. BMC Neuroscience 2010, 11:74
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Figure 6 Phosphorylation of tau is increased by GT1b treatment in mesencephalic cultures. Double-immunostaining with AT8 (Ser202; green)) 
for phospho-tau and TH (red) for DA neurons in mesencephalic cultures treated with vehicle (A) or 20 μg/ml GT1b (B) for 8 h. (D-I) Double-immunos-
taining showed Tau hyperphosphorylation in the GT1b-injected SN. SN tissues were prepared 72 h after PBS (D-F) or GT1b (60 μg/3 μl, G-I) injection, 
processed for immunostaining with TH antibody alone (C), double-immunostaining with AT8 (D, G, green) and TH (E, H, red) antibody, and then both 
images were merged (F, I). Scale bar, 10 μm in A-C, 200 μm in F and 50 μm G-I. SNpc, substantia nigra pars compacta; SNr, substantia nigra reticulata; 
VTA, ventral tegmental area. (J,K) Cell lysates were analyzed by Western blot analysis with AT8 (Ser202) antibody at indicated time points. After mem-
brane stripping, blots were then reprobed with actin antibody. The histogram shows quantitation of tau phosphorylation. (L.M) Tau phosphorylation 
is reversed by L803-mt, GSK-3 inhibitor in GT1b-treated mesencephalic cultures. The histogram shows quantitation of tau phosphorylation. The values 
represent the mean ± SEM of triplicate cultures in three to five separate samples. *P < 0.001, **P < 0.01 significant from non-treated cultures; #P < 0.01, 
significant from GT1b-treated cultures (ANOVA and Student-Newman-Keuls analyses). C, control; G, GT1b; L, L803mt.Chung et al. BMC Neuroscience 2010, 11:74
http://www.biomedcentral.com/1471-2202/11/74
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Discussion
Increasing evidence has shown that gangliosides enhance
cell death in various cell types. For example, GM1 and
GT1b produce an increase of cell death in feline thymo-
cytes [21]. GM3 causes apoptosis, decreases BrdUrd
incorporation, and up-regulates the cdk inhibitor p27 kip
in proliferating astrocytes [31]. Many studies also demon-
strate that, GD3 disrupts mitochondria membrane
potential [32,33], induces cell death and activates cas-
pases in HuT78, derived from a human cutaneous T cell
lymphoma [34]. Similarly, neurotoxicity of major brain
gangliosides, such as GD1a and GD1b against dopamin-
ergic neurons in mesencephalic cultures has been
reported [35]. We also found that GT1b was neurotoxic
to mesencephalic dopaminergic neurons in vivo and in
vitro [23,24]. This is consistent with our present findings
that GT1b neurotoxicity produces DNA cleavage as well
as condensation and fragmentation of nuclei, as evident
from the TUNEL reaction, Hoechst 33258 nuclear stain-
ing and immunoelectron microscopic observations,
respectively.
GT1b neurotoxicity is not mediated by caspase-3
Nuclear DNA damage occurs due to activation of cas-
pase-3, which appears to be a major effector of DA neu-
ronal cell death in human PD patients [1], animal models
of PD [4], and MPP+-treated rat mesencephalic cultures
[13] and SN-derived DA cell lines [36]. Regarding this,
our data indicated that GT1b-induced nuclear DNA
damage was accompanied by caspase-3 activation, which
was effectively suppressed by the specific inhibitor,
DEVD (Figure 3A). However, the caspase-3 inhibitor,
DEVD, and the non-specific caspase inhibitor, Z-VAD,
w e r e  u n a b l e  t o  b l o c k  G T 1 b - i n d u c e d  n e u r o t o x i c i t y ,  a s
confirmed from the number of TH-ip neurons and level
of [3H]dopamine uptake in mesencephalic cultures (Fig-
ure 3B). These results carefully suggest that under our
experimental conditions, caspase-3 may not be a major
effector of GT1b-induced DA neuronal cell death. This
hypothesis is supported by recent findings that inhibition
of caspases, including caspase-3, does not always prevent
neuronal death in MPP+-treated cerebellar granule neu-
rons [37], proteasome inhibitor-mediated death of HT4
cells (hippocampal cell line) [38], and global ischemia-
induced hippocampal neurodegeneration [39]. Moreover,
a wide range of caspase inhibitors, including DEVD, had
no effects on cytotoxicity induced by another major brain
ganglioside, GD3, in rat hepatocytes [32] and HuT78, a
cell line derived from a human cutaneous T cell lympho-
mas [34].
The Akt/GSK-3β/tau signaling pathway is implicated in 
GT1b neurotoxicity
Akt, a serine/threonine protein kinase, is significantly
associated with neuronal survival/degeneration [5,26]. In
particular, decreased Akt signaling is associated with
neurodegeneration in the brains of MPTP [40,41] or 6-
OHDA-induced Parkinsonism [42] and Drosophila mod-
els of PD [43]. Moreover, several studies demonstrate that
transduction of DA neurons with myristoylated Akt
(Myr-Akt), [7] and increasing phospho-Akt in LINGO-1
knockout mice [8] provide potent protection against 6-
OHDA- or MPP+-induced cellular and functional damage
of DA neurons, respectively, consistent with our present
observation that GT1b neurotoxicity is associated with
dephosphorylation/inactivation of Akt. The result is fur-
ther supported by previous findings that GT1b-induced
apoptosis is mediated by decreased phosphorylation of
Akt in keratinocyte-derived SCC12 cells [44], and GT1b
depletion increases cell survival through Akt activation
[22].
Akt contains two regulatory phosphorylation sites,
Thr308 and Ser473. While phosphorylation at both sites
is dependent on phosphoinositide 3-OH kinase (PI3K),
the mechanism of Ser473 phosphorylation remains con-
troversial. In this regard, there is evidence suggesting that
the Ser473 site is autophosphorylated [45,46] or phos-
phorylated by distinct serine kinase, including the integ-
rin-linked kinase (ILK) [27,47]. In SSC12 cells, GT1b-
induced cell death is mediated by inhibiting phosphoryla-
tion of Akt at Ser473, but not Thr308, through inactiva-
tion of ILK that does not require PI3K [22,44]. Data from
the present study show that GT1b neurotoxicity is
accompanied by Akt dephosphorylation at both Ser473
and Thr308. Therefore, it is likely that in mesencephalic
cultures, ILK or PI3K signaling or both participate in
GT1b neurotoxicity. However, we did not provide direct
evidence of whether GT1b neurotoxicity is mediated by
ILK or PI3K signaling or both.
The anti-apoptotic function of Akt involves phosphory-
lation/inactivation of its downstream substrate, GSK-3β.
Inactivation of Akt triggers GSK-3β activity through
decreasing phosphorylation, which plays a key role in
neuronal loss occurring in neurodegenerative diseases,
s u c h  a s  P D  [ 9 , 4 8 ]  a n d  A D  [ 6 ] .  T w o  P D  m i m e t i c s ,  6 -
OHDA and MPP+, induce GSK-3β-dependent neurode-
generation in cell types, including SH-ST5Y, PC12, and
cerebellar granule neurons [10,28], suggesting that GSK-
3β is a key mediator of neuronal death. Our results show
that in mesencephalic cultures, GT1b induces dephos-
phorylation of GSK-3β, indicative of GSK-3β β involve-
ment. This finding is further supported by TH
immunocytochemistry data showing that blockage of
GSK-3β activation by the inhibitor, L803-mt, leads to
reduced GT1b neurotoxicity.
Our results are comparable with recent reports show-
ing that suppression of GSK-3β β activity with selective
inhibitors, such as indirubin-3'-oxime and AR-A014418,
prevents MPTP-induced loss of DA neurons in vivo [9],
and novel synthetic inhibitors for GSK-3β protect DAChung et al. BMC Neuroscience 2010, 11:74
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neurons against MPP+ toxicity in mesencephalic cultures
via suppression of α-synuclein protein expression [48].
These results collectively imply that GT1b induces DA
neuronal death through the Akt/GSK-3β signaling path-
way (Figure 7).
Tau is one of the major microtubule-associated pro-
teins identified in neurons. Hyperphosphorylation of tau
inhibits its binding to microtubules, leading to neuronal
death [49-51] and is mediated by several protein kinases,
including GSK-3β [12]. Our Western blot and double
immunostaining data show that in parallel with increased
GSK-3β activity, GT1b induces tau hyperphosphorylation
in mesencephalic DA neurons in vivo and  in vitro. In
addition, L803-mt, a GSK-3β inhibitor, attenuates tau
phosphorylation, suggesting that GT1b neurotoxicity is
mediated by the GSK-3β/tau signaling pathway.
Conclusions
In the present study, we show that GT1b neurotoxicity is
associated with inhibition of Akt, resultant activation of
GSK-3β and increasing cleavaged tau as well as phospho-
rylation in mesencephalic neurons including DA neuron.
Interestingly, while GT1b activates caspase-3, a key mole-
Figure 7 Schematic drawing of Akt/GSK-3β/tau signaling. Akt is activated in response to ILK or PI3 Kinase signaling, and subsequent activation of 
Akt. Akt is activated in response to ILK or PI3 kinase signaling, and subsequent activation of Akt. Activated Akt phosphorylates GSK-3β at Ser 9, leading 
to GSK-3β inactivation. Akt inactivation by GT1b induces dephosphorylation of GSK-3β, leading to GSK-3β activation. GSK-3β activation results in ab-
errant tau phosphorylation, axon instability, and neuronal death. Although we did not provide direct evidence of whether GT1b neuroxocicity is me-
diated by ILK or PI3K signaling or both, participation of GT1b in inhibition of Akt upstream signals, such as ILK or PI3K, is predicted.Chung et al. BMC Neuroscience 2010, 11:74
http://www.biomedcentral.com/1471-2202/11/74
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cule of DA neuronal death, inhibition of caspase-3 fails to
rescue DA neurons. Our data collectively suggest that
GT1b neurotoxicity is associated with Akt/GSK-3β/tau,
but not with caspase-3.
Methods
Materials
Materials were purchased from the following companies:
mouse anti-tyrosine hydroxylase (TH; Pel-Freez, Rogers,
AR, USA), rabbit anti-tyrosine hydroxylase (TH; Pel-
Freez), mouse anti-neuron specific nuclear protein
(NeuN; Chemicon, Temecula, CA, USA), rabbit anti-
GABA and mouse anti-actin (Sigma, St. Louis, MO,
USA), rabbit anti-phospho-Akt (Ser473), rabbit anti-
phospho-Akt (Thr308), rabbit anti-phospho-GSK-3β
(Ser9), rabbit anti-Akt and rabbit anti-GSK-3β (Cell Sig-
naling Technology, MA, USA), mouse anti-AT8 (phos-
pho-tau (Ser202), INOGENETICS, Gent, Belgium),
biotinylated secondary antibody and ABC kit (Vector
Laboratory, Burlington, CA, USA), FITC-conjugated
anti-mouse IgG and Texas Red-conjugated anti-rabbit
IgG (Molecular Probes, OR, USA). GT1b (Matreya,
Pleasant Gap, PA), DEVD-FMK (Biochemicals, San
Diago, CA), z-DQMD-FMK (Tocris Elliscille, MO), z-
VAD (R&D systems Minneapolis, MN), L803-mts (Cal-
biochem, San Diego, CA, USA), tritiated dopamine
([3H]dopamine; Amersham, Oakville, ON, USA), Apotag
fluorescein  in situ detection kit (Chemicon), Hoechst
33258 (Molecular Probes), ApoAlert Caspase Fluorescent
Assay Kits (CLONTECH Laboratories, Palo Alto, CA,
USA), Akt kinase Assay Kit (Cell Signaling Technology).
Mesencephalic cultures
Neuron-enriched mesencephalic cultures were prepared
as previously described with some modifications [24]. In
brief, cells from the ventral mesencephalons of embry-
onic day 14 Sprague-Dawley rats were seeded on 12 mm
round aclar plastic coverslips or culture plates pre-coated
with 100 μg/ml poly-D-lysine (Sigma) and 4 μg/ml lami-
nin (Upstate Biotech, NY, USA) at a density 1.25~2 × 105
cells/cm2. The cultures were incubated in a humidified
incubator at 37°C, 5% CO2 for 24 h. To suppress the pro-
liferation of glial cells, on the second day in vitro (DIV2),
the media were replaced with a chemically defined
serum-free media (DM) composed of Ham's nutrient
mixture F12/DMEM and supplemented with ITS (insu-
lin, transferrin and sodium selenite; Sigma), glucose, L-
glutamine and penicillin/streptomycin (P/S). On DIV 4,
cultures were treated with various concentrations of
GT1b in DM without ITS. As described previously, the
cell composition included ~5% astrocytes and less than
1% microglia which were glial fibrillary acidic protein
(GFAP; Sigma) immunopositive (ip) and CD11b (OX-42,
Serotec, Oxford, UK)-ip cells, respectively. The remain-
ing cells were presumed to be neurons, 4.5~6% and
9.5~11% of which were tyrosine hydroxylase-ip (TH-ip)
and gamma amino butyric acid (GABA, ; Sigma)-ip neu-
rons, respectively [35].
Immunocytochemistry
As previously described [24,35], paraformaldehyde-fixed
cells were immunostained with following cell type spe-
cific antibodies; mouse-neuron specific nuclear protein
(NeuN, 1:300) for general neurons, mouse-TH (1:7500)
for DA neurons or rabbit-GABA (1:2000) for GABAergic
neurons. Cultures were incubated with a primary anti-
body for overnight at room temperature (RT) and subse-
quently incubated with an appropriated biotinylated
secondary antibody. Immunostaining was visualized by
the ABC method followed by color development with
diaminobenzidine (DAB; Sigma), and analysed under a
bright-field microscope (Olympus, Tokyo, Japan).
Measurement of Dopamine Uptake
The measurement of dopamine uptake was performed as
our described previously [24,35]. Briefly, cultures were
washed twice with the incubation solution (HBSS con-
taining 10 mM HEPES, 0.6% glucose, 0.2 mM pargyline,
and 0.01% ascorbic acid, pH 7.4), and then incubated at
37°C for 20 min in incubation solution with a final con-
centration of 83.3 nM tritiated dopamine ([3H]dopamine,
444 GBq/mmol). Blank values were obtained by incubat-
ing cultures at 0°C. The reaction was terminated by
removal of the solution followed by three rapid washes
with ice-cold incubation solution. The cultures were then
lysed with lysis buffer (0.2 M NaOH containing 0.2% Tri-
ton X-100) and transferred to scintillation vials for count-
ing.
TUNEL assay
The TUNEL assay was performed using the Apotag fluo-
rescein in situ detection kit that detects the 3'-OH region
of cleaved DNA. Briefly, cultures were exposed to GT1b
20 μg/ml for indicated time points. And then cultures
were fixed with 4% paraformaldehyde in PB for 15 min at
RT. Subsequently, cultures were incubated with a mixture
of terminal deoxynucleotidyl transferase and reaction
buffer containing FITC fluorescein conjugated-digoxi-
genin-dUTP in a humidified chamber for 1 h at 37°C, and
washed in washing buffer for 10 min. Finally, cultures
were counterstained with 1 μg/ml Hoechst 33258 at RT
for 10 min, and viewed using an Olympus IX71 confocal
laser scanning microscope (Olympus, Tokyo, Japan).
Immuno-electron microscopy
Mesencephalic cultures were fixed using Karnovsky's fix-
ative solution (2% paraformaldehyde, 2% glutaraldehyde,
0.5% calcium chloride in cacodylate buffer, pH 7.2) for 30
min and then immunostained with mouse-TH antibody.Chung et al. BMC Neuroscience 2010, 11:74
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Subsequently, cultures were incubated with a biotinylated
anti-mouse IgG. Immunostaining was visualized by the
ABC method followed by color development with DAB.
Immunostained cultures were processed for an electron
microscope. In brief, cultures were washed with cacody-
late buffer, dehydrated in a series of graded ethanol, and
then embedded in epon mixture. Ultrathin sections were
cut using on Reichert Jung Ultracut S (Leica, Markham,
Ontario, Canada) and mounted on grids, stained with
uranyl acetate and lead citrate, and analyzed under a
Zeiss EM 902 A electron microscope (Carl Zeiss, Ger-
man).
Measurement of caspase activities
Caspase activity was determined using the ApoAlert Cas-
pase Fluorescent Assay Kits in mesencephalic cultures.
Briefly, cultures were treated with 20 μg/ml GT1b for
indicated time points. And then the harvested lysate was
centrifuged for 20 min at 14,000g and the supernatant (10
μg/ml) were incubated at 37°C in a reaction buffer adding
10 mM DTT with the fluorogenic substrate DEVD-AFC,
and the emitted fluorescence was measured in a Spec-
trometer-Luminescene (Perkin Elmer, Norwalk, CT,
USA).
Akt kinase activation
For Akt kinase assay, cultures were washed with ice-cold
phosphate-buffered saline (PBS), lysed with cell lysis buf-
fer (20 mM Tris-HCL, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium
pyrophosphate, 1 mM β-glycerophosphate, 1 mM
Na3VO4, 1 μg/ml leupeptin; Cell Signaling Technology)
adding 1 mM phenylmethylsulfonyl fluoride (PMSF).
Equivalent amounts of Akt were immunoprecipitated by
rabbit-Akt antibody prebound to protein A-agarose
beads, and kinase assays were carried out according to
the manufacturer's instruction manual of the Akt kinase
Assay Kit (Cell Signaling Technology). GSK-3α/β fusion
protein was used as the substrate for Akt. Immunopre-
cipitated Akt and phosphorylated GSK-3α/β were mea-
sured by Western blotting using Akt antibody and
phospho-GSK-3α/β (Ser 21/9) antibody, respectively.
Western blot analysis
Cultures were washed with ice-cold PBS, lysed with cell
lysis buffer adding 1 mM PMSF and protease inhibitor
mixture (Sigma). Equal amounts of protein (50 μg) were
mixed with loading buffer (0.125 M Tris-HCl, pH 6.8,
20% glycerol, 4% SDS, 10% mercaptoethanol, and 0.002%
bromophenol blue), boiled for 5 min, and separated by
SDS-PAGE. After electrophoresis, proteins were trans-
ferred to polyvinylidene difluoride (PVDF) membranes
(Millipore, Bedford, MA, USA) using an electrophoretic
transfer system (Bio-Rad, Hercules, CA, USA). The mem-
branes were then incubated for overnight at 4°C with one
of the following the specific primary antibodies: rabbit-
phospho-Akt (Ser473), rabbit-phospho-Akt (Thr308),
rabbit-phospho-GSK-3β (Ser9), and mouse-AT8 phos-
pho-tau (Ser202). After washing, the membranes were
incubated with HRP-conjugated secondary antibodies
(1:2000; Amersham Biosciences) for 1 h at RT. Finally, the
blots were developed with enhanced chemiluminescence
detection reagents. The blots were reprobed with anti-
bodies against rabbit-Akt, rabbit-GSK-3β r mouse-actin
(1:10000). For semiquantitative analyses, the densities of
bands on immunoblots were measured with the Com-
puter Imaging Device and accompanying software (Fujif-
ilm, Tokyo, Japan).
Infusion of GT1b and tissue preparation
F o r  i n f u s i o n  o f  G T 1 b  i n  t h e  S N ,  f e m a l e  S D  r a t s
(230~250g) were anesthetized with an injection of chloral
hydrate [360 mg/kg, intraperitoneal (i.p.) injection], posi-
tioned in a stereotaxic apparatus (Kopf Instrument,
Tujunga, CA, USA). Each rat received a unilateral admin-
istration of GT1b into the right SN [anteroposterior (AP)
5.3 mm, mediolateral (ML) 2.3 mm, dorsoventral (DV)
7.6 mm from bregma], according to the atlas of Paxinos
and Watson (1998). All injections were made using a
Hamilton syringe equipped with a 30S-gauge beveled
needle and attached to a syringe pump (KDScientific,
MA, USA). Infusions were made at a rate of 0.2 μl/min for
GT1b (60 μg in 3 μl distilled water). Animals were tran-
scardially perfused with saline solution containing 0.5%
sodium nitrate and heparin (10 U/ml) and fixed with 4%
paraformaldehyde dissolved in 0.1 M PB. Brains were
removed from the cranium, post-fixed for 1 h, washed in
0.1 M PB and immersed in 30% sucrose solution until
they sank. Tissues were sectioned at a thickness of 35 μm
using a sliding microtome. Every sixth serial section was
selected and processed for immunohistochemical stain-
ing.
Double-immunostaining
For immunofluorescence double labeling, cultures or tis-
sue sections were incubated in a combination of mouse-
AT8 antibody and rabbit-TH antibody. The next day, cul-
tures or tissue sections were rinsed and incubated with
FITC-conjugated anti-mouse IgG (1:200) and Texas Red-
conjugated anti-rabbit IgG (1:200) for 1 h at RT. Stained
cells were viewed using an Olympus IX71 confocal laser-
scanning microscope (Olympus).
Statistical analysis
All data are represented as the means ± SEM. The statis-
tical significance of differences was assessed using analy-
sis of variance (ANOVA), followed by Student-Newman-
Keuls analyses or Student's two-tailed t-test (SPSS forChung et al. BMC Neuroscience 2010, 11:74
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windows: Standard Version). Statistical significance was
defined as p < 0.05 for all analyses.
Additional material
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